Advanced Ovarian Cancer Treatment: Recent Updates in the Second- and Later-Line Maintenance Settings

Robert L Coleman, MD, FACOG, FACS, and Bradley J Monk, MD, FACOG, FACS, provide insights on treating patients with advanced ovarian cancer and the evolving treatment landscape.

EP. 1: Overview of Advanced Ovarian Cancer

May 30th 2023

Robert L Coleman, MD, FACOG, FACS, and Bradley J Monk, MD, FACOG, FACS, provide an overview of advanced ovarian cancer and discuss its prevalence and diagnosis process.

EP. 2: Role of Biomarkers in Advanced Ovarian Cancer

May 30th 2023

Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.

EP. 3: Role of PARP Inhibitors in Advanced Ovarian Cancer

May 30th 2023

Expert oncologists give an overview of PARP inhibitors available for the treatment of patients with advanced ovarian cancer and review adverse events seen with each agent.

EP. 4: Advanced Ovarian Cancer: Updated Indications for PARP Inhibitors in Second- and Later-Line Settings

May 30th 2023

Drs Coleman and Monk discuss what led to the recent withdrawal of several indications for PARP inhibitors in the treatment of advanced ovarian cancer.

EP. 5: Advanced Ovarian Cancer: Current Treatment Landscape in Second- and Later-Line Settings

May 30th 2023

Expert oncologists review the current PARP inhibitor treatment indications for patients with advanced ovarian cancer and discuss how to best manage patients who have been impacted by the recent updates to the PARP inhibitors.

EP. 6: Future Outlook of Advanced Ovarian Cancer Treatment

May 30th 2023

Comprehensive insights on unmet needs, ongoing research, and the future of advanced ovarian cancer treatment.